For Hospitals
One AGenomics API to satisfy entire hospital leadership.
AGenomics API is built keeping in mind hospital decision makers: from the CEO, CFO, CIO, and RCM Director, along with the billing team at the point of billing — and clinicians at the point of care.
For the CFO & RCM Director
Turn your highest-denial claims into your most predictable ones.
Some of your highest-value genomic and oncology claims sit in manual review — payers have no genomic-specific edit rules to clear them — then get denied when a companion-diagnostic gap surfaces too late.
AGenomics scores every claim before submission against UAE payer rules: eligibility, coding, medical necessity, pre-auth linkage, genomic justification, FWA risk. It names what's missing, and generates much of it from evidence the physician already saw.
Nothing changes in your Shafafiya connection, contracts or billing workflow. Book a 90-day pilot on one service line, before any wider commitment.
For Owners, CEO & Medical Director
One investment. Two budget lines. Safer care, cleaner revenue.
Precision medicine and revenue-cycle performance have always been separate initiatives, separate teams. AGenomics assumes that separation was never necessary — the data making a prescription safer is what a payer needs to approve the resulting claim.
Deployed once, it's shared infrastructure: one edge system feeding clinical decision support and revenue cycle, neither team changing tools. One investment, two board-level concerns — your hospital turning the UAE's genome investment into daily clinical and financial reality.
Prove it with your own data, before faith is asked for.
For the CIO & Data Officer
One endpoint. No rip-and-replace. Data residency by architecture.
AGenomics avoids the three hidden costs of precision-medicine projects: months of integration, a new system to learn, a vendor negotiation touching your HIS or clearinghouse contracts.
It connects through standards you already run — HL7 v2.x, FHIR R4, CDS Hooks — an endpoint added to existing configuration, not new infrastructure. It runs where your data lives: an edge container in your own data centre.
Genomic data stays in UAE jurisdiction: production on-premise inside your firewall, pilot on Azure UAE North.
For the Billing Team & COO
A fifteen-minute write-up becomes a ninety-second review.
Billing teams handling genomic and oncology claims know the pain: fifteen minutes hand-writing a medical-necessity narrative for one prior authorisation, a companion-diagnostic requirement discovered only when the denial letter arrives, a review queue full of claims payers can't process automatically.
AGenomics removes that work at the source. Every claim reaches your biller scored, with gaps named — missing MCG criterion, absent CDx result, unlinked pre-auth — most fixable in one click, and submitted to the clearinghouse in one more.
Your biller still reviews and decides — but in a few seconds per claim instead of 15–20 minutes starting from scratch.
For Clinicians
The genomic context you have — visible when it matters most, at the point of care.
Every physician knows the gap between what the chart holds and what's visible at prescribing. AGenomics closes it without a second system — reading the PGx report already in the patient's record, however it arrived there.
Prescribe a medication with a known drug–gene risk — codeine to a CYP2D6 poor metaboliser, clopidogrel to a CYP2C19 poor metaboliser — and you get a clear alert inside your existing prescribing screen, with the specific clinical reasoning before the order completes.
Severity-graded: a critical alert where warranted, a quiet note where it isn't. No genomic data on file? Where the absence carries real risk, it offers the test to order — with pre-authorisation prepared.
One service line. Ninety days. Your data, your decision.
No system replaced. No hospital-wide licence. No obligation at the end of the trial.